Serving patients and  transforming lives

Antibody engineering for promising drugs

A hope for finding a better tomorrow

Innovative research.  Transformative results.

Pioneering treatments for unmet needs

Dedicated to providing quality of life

what we do

NovelMed is an early stage biotechnology company developing humanized monoclonal antibodies for rare diseases with a specific focus on blocking certain parts of the immune system involved in the disease process. We believe that selective blockade of the complement system with our highly selective, high affinity, and high potency monoclonal antibodies is important for diseases with unmet need.  
learn more

Research & development

With a talented and experienced team, NovelMed is poised to continue on its path to develop life-changing therapies for patients. We are excited to move towards clinical validation of our products and welcome collaborators and partners who share our vision.
learn more